Molecular docking has demonstrated that isoliquiritigenin binds directly to Sirt1 and regulates the MAPK and Nrf-2 signalling pathways to neutralise inflammatory responses and oxidative stress and reverse the deterioration of renal function and renal fibrosis [177]. The gene discussed is SIRT1; the disease is renal fibrosis.